Neurology Central

Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy


Aim: Since prominent role in valproate metabolism is assigned to CYP2C9 in pediatric patients, the association between children’s CYP2C9-status and serum valproate concentrations or dose-requirements was evaluated. Materials & Methods: The contribution of CYP2C9 genotype and CYP2C9 expression in children (n = 50, Caucasian) with epilepsy to valproate pharmacokinetics was analyzed.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.